UCB Gets US FDA Approval for Psoriasis Drug
By Helena Smolak UCB received approval from the U.S. Food and Drug Administration for a drug to treat severe plaque psoriasis for which the company expects...
Helena Smolak Drug Administration Article Normal Biotechnology Services Healthcare Life Sciences Regulation Government Policy
Source: marketwatch.com